First report of potent and selective inhibitors of c-Src protein tyrosine kinase identified at Ariad Nov. 7, 2001
AP-5280, a polymer-linked platinum antitumor agent, shows promising preclinical activity Nov. 7, 2001
Monoclonal antibody targeting human FLT-1 effective in human breast cancer xenograft model Nov. 7, 2001
MTD not reached in ongoing phase I trials of PKI-166, an EGF receptor tyrosine kinase inhibitor Nov. 6, 2001
Raf kinase inhibitor Bay-43-9006 advances through phase I trials without significant toxicity Nov. 5, 2001